Search Orphan Drug Designations and Approvals
-
Generic Name: | eflornithine plus sulindac |
---|---|
Date Designated: | 01/22/2013 |
Orphan Designation: | Treatment of familial adenomatous polyposis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
One-Two Therapeutics Assets Limited ("One-Two") Carrick House, 49 Fitzwilliam Square Dublin 2 Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
-